logo

For the Inventor, By the Inventor

Encinitas, CA, United States of America

Anna Galkin

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Novartis Ag. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Galkin. Retrieved from https://idiyas.com/inventor/anna-galkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal3 out of 3,977 
 
Novartis Ag
 patents

Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents
1. 12180291 - Anti-CCR7 antibody drug conjugates (2024-12-31),
2. 11939397 - ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies (2024-03-26),
3. 11634497 - Anti-CCR7 antibody drug conjugates (2023-04-25),

Title: The Innovative Journey of Anna Galkin

Introduction: Anna Galkin, a pioneering inventor based in Encinitas, CA, has been making significant contributions to the world of technology and innovation.

Latest Patents: Anna Galkin's latest patents focus on sustainable energy solutions and advanced medical devices, showcasing her versatility and forward-thinking approach.

Career Highlights: With a background in engineering and a passion for problem-solving, Anna Galkin has led groundbreaking projects in renewable energy, healthcare, and consumer electronics.

Collaborations: Throughout her career, Anna Galkin has collaborated with leading research institutions, universities, and tech companies to bring her innovative ideas to life and create real-world impact.

Conclusion: Anna Galkin's dedication to pushing the boundaries of innovation and her commitment to creating a better future through technology make her a true trailblazer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…